Consun Pharmaceutical Group Ltd

C1P

Company Profile

  • Business description

    Consun Pharmaceutical Group Ltd is a biotechnology company with a modern pharmaceutical enterprise that integrates R&D, production, and marketing. The company has two reportable segments: the Consun pharmaceutical segment, which is the key revenue driver, and makes and sells modern Chinese medicines and medical contrast medium, and the Yulin pharmaceutical segment, which manufactures and sells traditional Chinese medicines. Company derives revenue from kidney medicines, contrast mediums, orthopedics medicines, dermatologic medicines, hepatobiliary medicines, medicines for women and children, and others.

  • Contact

    71, Dongpeng Avenue
    Eastern section
    Guangzhou Economic and Technological Development
    Guangzhou
    CHN

    T: +86 2082264529

    https://www.chinaconsun.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    3,115

Stocks News & Analysis

stocks

Ask the analyst: Where does GYG stand following its US exit?

All roads lead back home for Guzman Y Gomez.
stocks

Chart of the Week: The long term headwinds facing copper shares

The key factors challenging the bull case for copper demand.
stocks

Australia’s oldest REIT undervalued

This REIT remains undervalued as trophy properties shine through.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,048.3074.600.83%
CAC 408,508.0733.210.39%
DAX 4025,779.31198.430.78%
Dow JONES (US)52,900.07594.831.14%
FTSE 10010,679.0326.160.25%
HKSE23,350.03295.001.28%
NASDAQ25,832.67207.36-0.80%
Nikkei 22569,744.071,010.921.47%
NZX 50 Index13,618.4236.230.27%
S&P 5007,483.240.010.00%
S&P/ASX 2008,844.4075.100.86%
SSE Composite Index4,043.6414.740.37%

Market Movers